AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference

Core Insights - AVITA Medical, Inc. is a leading company in therapeutic acute wound care, focusing on innovative solutions for wound healing [3][4] - The CEO, Jim Corbett, will present at TD Cowen's 45th Annual Health Care Conference on March 4, 2025 [1] - The RECELL® System is a key product that utilizes a patient's own skin to create Spray-On Skin™ Cells, enhancing clinical outcomes [3] Company Overview - AVITA Medical specializes in technologies that optimize wound healing and accelerate patient recovery [3] - The RECELL® System is FDA-approved for treating thermal burn wounds and full-thickness skin defects [3] - The company also markets Cohealyx™, a collagen-based dermal matrix, and PermeaDerm®, a biosynthetic wound matrix in the U.S. [3] International Approvals - The RECELL System is approved for various applications in international markets, including burns and skin defects [4] - It holds TGA registration in Australia, CE mark approval in Europe, and PMDA approval in Japan [4]